Jin-long Chen, Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC (NGM), sold 59,830 shares at $26.17 ($1.5M) on 2021-09-13, disclosed to the SEC on 2021-09-14.
Open-market sale of $1.5M NGM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.59 | 3,920 | $100K | 6.5% |
| 2 | $25.59 | 3,920 | $100K | 6.5% |
| 3 | $26.17 | 10,910 | $286K | 18.5% |
| 4 | $26.17 | 10,910 | $286K | 18.5% |
| 5 | $26.98 | 170 | $5K | 0.3% |
| 6 | $25.54 | 11,963 |
| $306K |
| 19.8% |
| 7 | $25.54 | 11,963 | $306K | 19.8% |
| 8 | $26.13 | 3,037 | $79K | 5.1% |
| 9 | $26.13 | 3,037 | $79K | 5.1% |
| Total | $25.84 avg | 59,830 | $1.5M | 100% |
| Filing → |
| NGM | SELL | 2021-11-16 | $592K | — | Filing → |
| NGM | SELL | 2021-10-13 | $608K | — | Filing → |
| NGM | SELL | 2021-08-11 | $1.1M | — | Filing → |